Otitis Media, Otitis Media With Effusion, Pneumococcal Infections
Conditions
Keywords
Middle Ear Infection
Brief summary
The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.
Interventions
DRUGPrevenar
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
Study design
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
6 Months to 24 Months
Healthy volunteers
No
Inclusion criteria
* Infants aged from 6 to 24 months * Presenting with AOM (ear infection) * Patients must not have received any antibiotic therapy within the past 7 days. Other inclusion applies.
Countries
France
Outcome results
None listed